Our Promise
With a relentless commitment to quality and compassion, we strive to bridge the gap between complex pharmaceutical innovations and the communities that need them the most. Our purpose is fueled by the belief that every person deserves access to the medicines that can enhance their lives, regardless of location or circumstance. By forging strong relationships with healthcare providers, regulatory bodies, and international partners, we aim to become the trusted ally in the fight against rare diseases, standing as a beacon of hope and progress in Kazakhstan's healthcare landscape.
At SwissKazMed, we dedicate ourselves to the pursuit of health and well-being for all individuals across Kazakhstan. Recognizing the unique challenges faced by those in need of rare medications, our core mission is to ensure the reliable, timely, and equitable distribution of these vital treatments throughout the country.
Metrics
-
Innovative Medicine Focus: The company stands out due to its commitment to securing agreements with world-leading medical manufacturers, guaranteeing the most innovative and effective medicines for rare diseases are available in Kazakhstan.
-
Global Quality Standards: By working with the highest quality medical manufacturers across the globe, the company ensures that every medicine distributed meets stringent international quality standards, which distinguishes them from competitors.
-
Comprehensive Care Approach: Unlike many competitors, the company goes beyond mere distribution; it focuses on holistic patient care through support programs, education, and collaboration with healthcare providers to improve treatment outcomes.
-
Tailored Distribution Strategies: Understanding the vast geography of Kazakhstan, the company develops specialized distribution methods to reach the most remote areas, ensuring equitable access to crucial medications where competitors may not have a presence.
Our Best-Selling Products
Dosage Form
Tablets, film-coated 62.5 mg and 125 mg
Indications for Use
-
Primary (idiopathic and hereditary) pulmonary arterial hypertension
-
Secondary pulmonary arterial hypertension associated with scleroderma without significant interstitial lung disease
-
Pulmonary arterial hypertension due to congenital heart defects with hemodynamic disorders in the type of Eisenmenger's syndrome
-
Prevention of new ulcerative skin lesions in scleroderma-related acropathy
Bosentan
01
Dosage Form
Extended-release tablets, film-coated 500 mg and 1000 mg
Indications for Use
-
Stable angina
Ranolazine
02
Dosage Form
Film-coated tablets, 25 mg, 50 mg
Indications for Use
-
As an adjunct to standard therapy (including beta-blockers) to reduce the risk of cardiovascular morbidity and mortality in patients with stable left ventricular dysfunction (ejection fraction <40%) and clinical signs of heart failure after a recent myocardial infarction in stable patients;
-
As an adjunct to standard optimal therapy to reduce the risk of cardiovascular morbidity and mortality in patients with left ventricular systolic dysfunction (ejection fraction <30%) and chronic heart failure NYHA class II.
Eplerenone
03
Dosage Form
Film-coated tablets, 10 mg and 20 mg
Indications for Use
-
Primary hypercholesterolemia (type IIa including familial heterozygous hypercholesterolemia in adults and children aged 10-17 years) or mixed hypercholesterolemia (type IIb) as an adjunct to diet when diet and other non-pharmacological treatments (e.g., physical exercise, weight reduction) are inadequate.
-
Familial homozygous hypercholesterolemia as an adjunct to diet and other cholesterol-lowering therapy (e.g., LDL apheresis) or when such treatments are not suitable for the patient.
-
As an adjunct to diet to slow the progression of atherosclerosis in adult patients as part of therapy to reduce total cholesterol (TC) and LDL-C to target levels.
Rosuvastatin
04
Dosage Form
Sublingual solution.
Indications for Use
-
Treatment of type I allergic diseases (IgE-mediated), such as allergic rhinitis, allergic conjunctivitis, and mild allergic bronchial asthma, caused by hypersensitivity to unavoidable allergens.
Sulgen
05
Dosage Form
1000 TSU/ml, suspension for injection
Indications for Use
This medication is prescribed for managing allergic reactions triggered by inescapable allergens like mold, including:
-
Allergic nasal inflammation, which may also be administered alongside regulated asthma treatments;
-
Inflammatory conditions of the eye's conjunctiva due to allergies (known as conjunctivitis);
-
With consistent administration of ROXSIT S, the allergenic substance is incrementally introduced into your system. This process aids in acclimatizing your immune response to the allergen, thereby diminishing your allergic sensitivity.
Roxsit S
06
.jpg)
Dosage Form
10,000 TSU/ml, suspension for injection
Indications for Use
-
It is used to treat allergies caused by unavoidable allergens such as pollen, dust mites, or animal epithelium:
-
Allergic rhinitis, possibly in combination with controlled asthma
-
Conjunctival inflammations of the eye associated with allergy (conjunctivitis)
Regular use of CLUSTOID provides a slow introduction of the substance you are allergic to into your body. This allows your immune system to get used to the substance that triggers the allergy and to reduce your sensitivity to it.
Clustoid
07
